Peter Hersey

6PUBLICATIONS
11CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 10, 2024
BET inhibition sensitizes innate checkpoint inhibitor resistant melanoma to anti-CTLA-4 treatment.

Hsin-Yi Tseng, Sara Alavi, Stuart Gallagher

|Jan 21, 2022
Nicotinamide Inhibits T Cell Exhaustion and Increases Differentiation of CD8 Effector T Cells.

Sara Alavi, Abdullah Al Emran, Hsin-Yi Tseng

|Jan 20, 2021
Sex bias of females in survival from cancer and infections. Is X the answer?

Abdullah Al Emran, Stuart J Gallagher, Jessamy C Tiffen

|Feb 07, 2020
Do innate killing mechanisms activated by inflammasomes have a role in treating melanoma?

Abdullah Al Emran, Hsin-Yi Tseng, Mikaela C Coleman

Pageof 1